European Archives - Page 821 of 1138 - European Medical Journal

Dedicated Bifurcation Cobalt-Chromium Sirolimus-Eluting Stent in the Treatment of Distal Left Main Stenosis: Optical Coherence Tomography Evaluation of the Stent Healing Pattern

The optimal form of treatment for left main (LM) coronary artery disease, a form of atherosclerosis, is still debated. The aim of this study was to…

Lung Cancer Nurse Specialists Linked to Improved Patient Outcomes

Lung cancer patients experience better outcomes when they are cared for by lung cancer nurse specialists (LCNS), according to researchers from the…

Challenges and Solutions in the National Health Service (NHS)

As the UK’s National Health Service (NHS) enters the eighth decade of its life, there are many well-documented challenges that the institution is facing.

"Patient, trust, reputation, and business. Those four areas, in that order of priority, are how we go about our work."

Patient, Trust, Reputation, Business: the starting point of EMG’s conversation with Dion Warren and the pillars that underpin the talk with the Head of…

EuroPCR 2018 - Congress Highlights

Step centre stage into our congress highlights, and get an insight into the venue of this year’s EuroPCR annual meeting.

The Foundation of the NHS

The British National Health Service (NHS), a unique healthcare system respected throughout the world, is celebrating its 70th birthday this week.

Gut–Brain Axis and the Impact on Memory

Gut–brain signalling is a topic of paramount importance in modern biology and medicine. It is understood that the bidirectional signalling, mainly via…

An Early Marker of Inflammatory Bowel Disease

Cell communication has been shown to be a contributing factor to intestinal inflammation, according to work carried out by scientists at Michigan State…

This June 2018, EMJ Supports…

This June, EMJ has proudly showcased its support for Diabetes Week and Motor Neurone Disease Awareness Month.

Merck KGaA’s Ulrich Betz on leading innovation in pharma

Dr Ulrich Betz, Vice President of Innovation, Merck KGaA, talks about the evolution of R&D in the pharma space, the use of AI in pharma clinical trial models and fostering a creative team culture.